Precision medicine: the foundation of future cancer therapeutics

por Seung Ho Shin, Ann M. Bode, Zigang Dong
Publicado 2017

Effects of systemic inflammation on relapse in early breast cancer

por Nicholas P. McAndrew, Lisa Bottalico, Clementina Mesaros, Ian A. Blair, Patricia Y. Tsao, Jennifer M. Rosado, Tapan Ganguly, Sarah J. Song, Phyllis A. Gimotty, Jun J. Mao, Angela DeMichele
Publicado 2021

A tumor microenvironment-specific gene expression signature predicts chemotherapy resistance in colorectal cancer patients

por Xiaoqiang Zhu, Xianglong Tian, Linhua Ji, Xinyu Zhang, Yingying Cao, Chaoqin Shen, Ye Hu, Jason W. H. Wong, Jing-Yuan Fang, Jie Hong, Haoyan Chen
Publicado 2021

Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling

por Feng Liu, Paul S. Mischel, Webster K. Cavenee
Publicado 2017

Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care

por Ugljesa Djuric, Gelareh Zadeh, Kenneth Aldape, Phedias Diamandis
Publicado 2017

Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic

por Fenil Shah, Derek Logsdon, Richard A. Messmann, Jill C. Fehrenbacher, Melissa L. Fishel, Mark R. Kelley
Publicado 2017

Immune cell profiling in cancer: molecular approaches to cell-specific identification

por Yasmin A. Lyons, Sherry Y. Wu, Willem W. Overwijk, Keith A. Baggerly, Anil K. Sood
Publicado 2017

Towards personalized tumor markers

por Vathany Kulasingam, Ioannis Prassas, Eleftherios P. Diamandis
Publicado 2017

The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients

por Sunao Tanaka, Takayuki Ueno, Hiroshi Ishiguro, Satoshi Morita, Masakazu Toi
Publicado 2017

EBV based cancer prevention and therapy in nasopharyngeal carcinoma

por Ya Cao
Publicado 2017

Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients

por Ali Bohlok, Peter Vermeulen, Sophia Leduc, Emily Latacz, Lara Botzenhart, François Richard, Maxim De Schepper, Tatjana Geukens, Valerio Lucidi, Michail Ignatiadis, Philippe Aftimos, Christos Sotiriou, Martine Piccart, Alain Hendlisz, Steven Van Laere, Luc Dirix, Jean-Christophe Noël, Elia Biganzoli, Denis Larsimont, Christine Desmedt, Vincent Donckier
Publicado 2020

Inherited predisposition to breast cancer in the Carolina Breast Cancer Study

por Tom Walsh, Suleyman Gulsuner, Ming K. Lee, Melissa A. Troester, Andrew F. Olshan, H. Shelton Earp, Charles M. Perou, Mary-Claire King
Publicado 2021

Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L/CRR9-mediated chemotherapeutic drug resistance

por Deepak Parashar, Anjali Geethadevi, Donna McAllister, Johnathan Ebben, Francis C. Peterson, Davin R. Jensen, Erin Bishop, Sunila Pradeep, Brian F. Volkman, Michael B. Dwinell, Pradeep Chaluvally-Raghavan, Michael A. James
Publicado 2021

Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor

por Sumanth Nagabushan, Loretta M. S. Lau, Paulette Barahona, Marie Wong, Alexandra Sherstyuk, Glenn M. Marshall, Vanessa Tyrrell, Eva A. Wegner, Paul G. Ekert, Mark J. Cowley, Chelsea Mayoh, Toby N. Trahair, Philip Crowe, Antoinette Anazodo, David S. Ziegler
Publicado 2021

Fibroblast growth factor receptor facilitates recurrence of minimal residual disease following trastuzumab emtansine therapy

por Saeed S. Akhand, Hao Chen, Stephen Connor Purdy, Zian Liu, Joshua C. Anderson, Christopher D. Willey, Michael K. Wendt
Publicado 2021

Stabilization of p18 by deubiquitylase CYLD is pivotal for cell cycle progression and viral replication

por Yueshuo Li, Feng Shi, Jianmin Hu, Longlong Xie, Lin Zhao, Min Tang, Xiangjian Luo, Mao Ye, Hui Zheng, Min Zhou, Na Liu, Ann M. Bode, Jia Fan, Jian Zhou, Qiang Gao, Shuangjian Qiu, Weizhong Wu, Xin Zhang, Weihua Liao, Ya Cao
Publicado 2021

Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma

por Mary Kathryn Abel, Heather Greenwood, Tatiana Kelil, Ruby Guo, Case Brabham, Nola Hylton, Jasmine Wong, Michael Alvarado, Cheryl Ewing, Laura J. Esserman, Judy C. Boughey, Rita A. Mukhtar
Publicado 2021

Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics

por Allen Li, Jamie M. Keck, Swapnil Parmar, Janice Patterson, Marilyne Labrie, Allison L. Creason, Brett E. Johnson, Molly Downey, George Thomas, Carol Beadling, Laura M. Heiser, Annette Kolodzie, Alexander R. Guimaraes, Christopher L. Corless, Joe W. Gray, Gordon B. Mills, Raymond C. Bergan, Zahi I. Mitri
Publicado 2021

Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry

por Yash S. Huilgol, Holly Keane, Yiwey Shieh, Robert A. Hiatt, Jeffrey A. Tice, Lisa Madlensky, Leah Sabacan, Allison Stover Fiscalini, Elad Ziv, Irene Acerbi, Mandy Che, Hoda Anton-Culver, Alexander D. Borowsky, Sharon Hunt, Arash Naeim, Barbara A. Parker, Laura J. van ‘T Veer, Athena Breast Health Network Investigators and Advocate Partners, Laura J. Esserman
Publicado 2021

Quantitative MRI-based radiomics for noninvasively predicting molecular subtypes and survival in glioma patients

por Jing Yan, Bin Zhang, Shuaitong Zhang, Jingliang Cheng, Xianzhi Liu, Weiwei Wang, Yuhao Dong, Lu Zhang, Xiaokai Mo, Qiuying Chen, Jin Fang, Fei Wang, Jie Tian, Shuixing Zhang, Zhenyu Zhang
Publicado 2021